Rockefeller University: Clinical Trials Show New Antibody Therapy Offers Long-Lasting HIV Control Without Daily Medication
March 28, 2025
March 28, 2025
NEW YORK, March 28 -- Rockefeller University issued the following news:
* * *
Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication
If the past four decades have taught us anything about HIV, it's to adjust our expectations--despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it has taken hold. But promising results from a recent clinical trial suggest that . . .
* * *
Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication
If the past four decades have taught us anything about HIV, it's to adjust our expectations--despite enormous progress in controlling the virus, no treatment can yet completely eradicate HIV once it has taken hold. But promising results from a recent clinical trial suggest that . . .